Co-Located Conference AgendasBiodetection & Biosensors | Lab-on-a-Chip & Microfluidics | Microarray Technology | Point of Care Diagnostics |
Tuesday, 17 March 201508:00 | Registration | | Emerging Technologies |
| | | Session Chair: Harald Peter, Fraunhofer |
| | 09:00 | | Keynote Presentation Advanced Centrifugal Microfluidics for Point-of-Care Applications Roland Zengerle, Professor, University of Freiburg, Germany
Centrifugal microfluidics enables efficient miniaturization, integration, parallelization and automation of biochemical assays especially for Point-of-Care applications. This talk will demonstrate a fully integrated sample-to-answer genotyping assay from whole blood performed within 2 hours on a small and lightweight instrument. Novel and advanced centrifugal unit operations will be discussed such as integrated pneumatic pumping and automated bead handling. Finally, challenges and solutions for the scale-up of manufacturing the polymer LabDisk will be discussed.
|
| 10:00 | Coffee and Networking in Exhibition Hall | 10:45 | Cardiac Point of Care – Current Technology and Future Directions Paul Collinson, Consultant Chemical Pathologist, St Georges University Hospitals NHS Foundation Trust, United Kingdom
The rapid measurement of the gold standard biochemical test cardiac troponin by point of care testing (POCT) was an early innovation in patients presenting with chest pain. Strategies for more rapid diagnosis and the improved sensitivity of laboratory-based systems now create the challenge for troponin measurement by POCT. | 11:30 | Point of Care Detection of Antimicrobial Resistance with Impedance Biosensors Till Bachmann, Reader, University of Edinburgh, United Kingdom
| 12:15 | Lunch and Networking in Exhibition Hall | | 13:30 Poster Session | Session Sponsors |
| | | Session Chair: John Connor, Boston University |
| | 14:15 | Lab-on-a-chip Devices for Production and Quality Control of Dose-on-demand Radiotracers Nicole Pamme, Professor in Analytical Chemistry, Stockholm University, Sweden
Positron Emission Tomography is a medical imaging technique that relies on the selective distribution within tissue of radiopharmaceuticals such as [18F]FDG. Microfluidic devices have been identified as attractive technology for the synthesis and processing of these pharmaceuticals due to small amounts of radioactivity handled at any one time, leading to lower shielding requirements and potentially enabling the synthesis of one dose at a time near the patient, a “dose-on-demand”. | 15:00 | Clinical Validation of a Microfluidic Point-of-care Diagnostic System for Neonatal Sepsis - ASCMicroPlat Katherine McAllister, Research Scientist, Queens University Belfast, Ireland
Sepsis is a leading cause of infant death worldwide and patient management is challenged by diagnostic short-comings. The current gold standard for microbe-identification by blood culturing takes 2-3 days. Therefore a rapid diagnostic tool for sepsis-pathogen identification would facilitate earlier patient treatment, reducing infant morbidity and mortality. | 15:45 | Coffee and Networking in Exhibition Hall | 16:30 | "Lab-in-a-hanky" - What Comes Next after Lab-on-a-Chip Frank Bier, Professor / Head of Division Biosystems Integration & Automation, University of Potsdam / Fraunhofer IZI-BB, Germany
| 17:15 | Novell Chip-based Extraction of miRNA Gregory Dame, Group Leader, University of Freiburg, Germany
MicroRNAs (miRNAs) are highly conserved ~22 nt long regulatory RNAs and critical modulators of post-transcriptional gene regulation. Here we present the development of a fast on-chip (mi)RNA extraction system for point of care diagnostics, e.g. tumor analysis. | 18:00 | Drinks Reception |
Wednesday, 18 March 2015 | Point of Care Global Health |
| | | Session Chair: Nicole Pamme, Hull University |
| | 09:00 | | 10:00 | Coffee and Networking in Exhibition Hall | 10:45 | Development of a Point-of-Care Diagnostic for Influenza Detection with Antiviral Treatment Effectiveness Indication Richard Murdock, Biomedical Engineer, USAF, United States of America
Development of a point-of-care style µPAD (microfluidic paper-based diagnostic) for influenza with the ability to determine antiviral susceptibility of the strain for treatment decision. | 11:30 | | Keynote Presentation Direct, Multiplexed Detection of Hemorrhagic Fever Viruses John Connor, Associate Professor, Boston University, United States of America
The recent Ebola outbreak has highlighted both the deadly nature of hemorrhagic fever viruses and the difficulty of effectively identifying infected individuals using currently available diagnostics. My presentation will focus on a new approach for identifying viruses directly from patient samples that we hope will simplify the diagnostic process and make diagnosis easier in low resource setting. |
| 12:30 | Lunch and Networking in Exhibition Hall | | 13:30 Poster Session | Session Sponsors |
| | | Session Chair: Samuel Sia, Columbia University |
| | 14:00 | The Application of a Resonant Coil Magnetometer for Point of Care Diagnostic Applications Richard Luxton, Director, University of the West of England, United Kingdom
This presentation will detail the application of paramagnetic particles and magnetic detection technology, using a resonant coil, to develop rapid, sensitive point of care tests. | 14:45 | Implementing Point-of-care Testing to Optimise Drug Treatment Ana Alfirevic, Senior Lecturer, University of Liverpool, United Kingdom
In this presentation I will discuss several approaches to improve dosing of warfarin. | 15:30 | Coffee and Networking in Exhibition Hall | 16:00 | Highly-integrated Lab-on-a-chip System for Multiparameter Analysis at the Point-of-care Harald Peter, Research Scientist, Fraunhofer Institute for Cell Therapy and Immunology IZI-BB, Germany
The "Fraunhofer in-vitro diagnostics
platform" (ivD-Platform) is a diagnostic system, which enables the measurement of multiple diagnostic parameters directly at the point-of-care.
Immunological, serological and DNA-based applications will be presented. | 16:45 | Close of Conference |
|